Based on the presented evidence, combining patients’ survival analysis and in vitro and in vivo studies in TNBC model, we conclude that HDC may be a potential prognostic biomarker in breast cancer that could complement routine histopathological analysis. Here, HDC is linked to breast carcinoma.